Lokacin da ciwon hanta na farko yana hade da ascites, jaundice, m metastasis, da dai sauransu, ana kiran shi ciwon hanta na farko. Maganin ciwon daji na hanta na farko yana da wuyar gaske, kuma tasirin maganin asibiti bai dace ba. Tiyata ba zaɓi ba ne don magance ciwon hanta mai ci gaba saboda ya yadu zuwa ƙwayoyin lymph ko wasu gabobin.
Idan hanta yana cikin yanayi mai kyau (Child-Pugh grade A ko B), likita zai yi la'akari da magani tare da magungunan warkewa da aka yi niyya Sorafenib (Nexavar) ko Lenvama (Lenvima). Girma na iya tsawaita lokacin rayuwa na marasa lafiya. Idan mai haƙuri ya haɓaka juriya na miyagun ƙwayoyi, maganin da aka yi niyya na repaglinide (Stivarga) ko kuma immunotherapy Ana iya amfani da nivolumab (Opdivo) maimakon.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced ciwon daji. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
